Please note the Protocols are in PDF format and require Adobe Reader 5.0 or higher. If your computer has a lesser version of Adobe Reader installed the following links will probably open a new window with a blank screen. Please visit our File Formats page if you require further information.
The Transfusion Protocols presented on this site are for use within King Edward Memorial Hospital for Women and Princess Margaret Hospital for Children. The protocols are based on the National and International Blood Transfusion Protocols and are intended to promote better and safer Transfusion Practice.
1.1 The Prescription of Blood Components
1.4 Clinical Indications For Blood Products
2.1 Completion of PathWest Transfusion Request Form
2.2 Collection of Pre Transfusion Samples
2.3 Correct Patient Identification During Sample Collection
2.7 The Role of the Group and Hold Request
2.8 Pre Transfusion Testing for Neonates
2.9 Maximum Surgical Blood Order Schedule (MSBOS)
3.1 Urgent Blood Transfusion Requests
3.2 Emergency Uncrossmatched Blood
3.3 KEMH Massive Transfusion Guideline
4.2 Collection of Blood Components from the Blood Bank
4.3 Issue Via The Vacuum Transport System
4.4 Storage of Blood Outside the Blood Bank
5.1 General Considerations for Receipt of Blood Products
6.1 Pre Transfusion Checking Procedure
7.1 Standard Administration Checks and Filters
7.6 Calculating a Blood Transfusion Rate
8.1 Care and Monitoring of Transfused Patients
10.1 General Considerations in Adverse Events
10.2 Acute Transfusion Reactions
10.3 Delayed Haemolytic Transfusion Reactions
10.4 Other Delayed Complications
11.2 Paediatric Red Blood Cells
11.3 Platelets Single Donor Apheresis
11.6 Special Requirements for Blood Products
12.1 Overview of Plasma Derived Blood Components
12.7 Prothrombinex Factors II IX and X
12.11 Hepatitis B immunoglobulin
12.13 Intravenous Tetanus Immunoglobulin
13.1 Fetal Maternal Haemorrhage and Post Partum Complications
13.3 Anti D Immunoglobulin Products and Applications
14.1 General Considerations and Risks of Autologous Blood
14.2 Procedure for Autologous Blood Request
15.1 ICS General Considerations
16.1 General Information for Clinicians
16.3 Informed Consent in Directed Donation
16.4 ARCBS Donor Selection Criteria
16.5 Directed Donation Procedure
17.1 Background - Recombinant Factor VIIa
17.2 Guidelines for use of Recombinant Factor VIIa
18.1 Procedure for Receiving Blood